Work

1506P ctDNA testing based on deep NGS predicts treatment efficacy and prognosis in advanced pancreatic cancer patients

Year: 2024

Type: article

Abstract: Pancreatic ductal adenocarcinoma (PDAC) is a rapidly progressing cancer with poor prognosis. This study explores the utility of deep next-generation sequencing (NGS) of ctDNA for managing locally advanced or metastatic PDAC.

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.08.1569

Authors: T. You, H. Tang, Y. Cheng, X. Wang, Y. Wang, M. Yuan, R. Chen, C. Bai

Institution: Peking Union Medical College Hospital

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,600

OpenAlex ID: W4402560346

FWCI:

Cites:

Cited by:

Related to: 10